Highland Capital Management Fund Advisors, L.P. Ani Pharmaceuticals Inc Transaction History

Highland Capital Management Fund Advisors, L.P.

$865 Million
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $215,485 - $476,694	-7,100 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $459,370 - $606,269	7,100 New	7,100 $517,000

Others Institutions Holding ANIP

# of Institutions

213

Shares Held

19.2M

Call Options Held

3.4K

Put Options Held

10.8K

Black Rock Inc. New York, NY

2.66M
Shares

$180 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.31M
Shares

$88.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1M
Shares

$67.8 Million
0.03% of portfolio
State Street Corp Boston, MA

737K
Shares

$49.8 Million
0.0% of portfolio
Goldman Sachs Group Inc New York, NY

700K
Shares

$47.3 Million
0.01% of portfolio

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.18B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account